The Future of Anticoagulant Therapy

被引：1

作者：

Mousa, Shaker A. ^{[1
]}

机构：

[1] Albany Coll Pharm & Hlth Sci, Pharmaceut Res Inst, Albany, NY USA

来源：

CARDIOVASCULAR THERAPEUTICS | 2012年 / 30卷 / 05期

关键词：

ATRIAL-FIBRILLATION; THROMBOPROPHYLAXIS; ARTHROPLASTY; RIVAROXABAN; ENOXAPARIN;

D O I：

10.1111/j.1755-5922.2011.00281.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：255 / 256

页数：2

共 9 条

[1]

Apostolakis S, 2010, CARDIOVASC THER, DOI [10.1111/j.1755-5922.2010.00160.x, DOI 10.1111/J.1755-5922.2010.00160.X]

[2] New Antithrombotics for Atrial Fibrillation [J].

Bereznicki, Luke R. E. ;

Peterson, Gregory M. .

CARDIOVASCULAR THERAPEUTICS, 2010, 28 (05) :278-286

[3] Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty [J].

Eriksson, Bengt I. ;

Borris, Lars C. ;

Friedman, Richard J. ;

Haas, Sylvia ;

Huisman, Menno V. ;

Kakkar, Ajay K. ;

Bandel, Tiemo J. ;

Beckmann, Horst ;

Muehlhofer, Eva ;

Misselwitz, Frank ;

Geerts, William .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (26) :2765-2775

[4] Atrial Fibrillation and Dabigatran: Has the Time Come To Use New Anticoagulants? [J].

Escobar, Carlos ;

Barrios, Vivencio ;

Jimenez, David .

CARDIOVASCULAR THERAPEUTICS, 2010, 28 (05) :295-301

[5] Future of Anticoagulant Therapy [J].

Harenberg, Job ;

Wehling, Martin .

CARDIOVASCULAR THERAPEUTICS, 2011, 29 (05) :291-300

[6]

Kanagasabapathy P, 2010, CARDIOVASC THER, DOI [10.1111/j.1755-5922.2010.00197.x, DOI 10.1111/J.1755-5922.2010.00197.X]

[7] Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty [J].

Lassen, Michael R. ;

Ageno, Walter ;

Borris, Lars C. ;

Lieberman, Jay R. ;

Rosencher, Nadia ;

Bandel, Tiemo J. ;

Misselwitz, Frank ;

Turpie, Alexander G. G. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (26) :2776-2786

[8]

Mousa SA, 2010, METHODS MOL BIOL, V663, P157, DOI 10.1007/978-1-60761-803-4_5

[9]

Weitz JI, 2010, EUR J HAEMATOL, V85, P1, DOI 10.1111/j.1600-0609.2010.01461.x

← 1 →